Can Ezetimibe and Rosuvastatin Be Taken Together?
Ezetimibe and rosuvastatin can be taken at the same time without needing to space them out. Both medications are routinely prescribed together as combination therapy for cholesterol management, and there is no requirement to separate their administration times.
Evidence Supporting Concurrent Administration
FDA-Approved Combination Use
The FDA-approved prescribing information for ezetimibe explicitly states that it can be taken "with or without food" and makes no mention of timing restrictions when combined with statins 1. The drug label specifically indicates ezetimibe is approved "in combination with a statin" for reducing LDL-C in adults and pediatric patients 1. This regulatory approval inherently supports concurrent administration.
Clinical Guidelines Support Combination Therapy
The 2022 ACC Expert Consensus Decision Pathway recommends ezetimibe as a nonstatin agent that can be combined with statins, with dosing specified as "10 mg orally daily, with or without food" 2. The guidelines make no distinction about timing relative to statin administration, indicating concurrent dosing is acceptable.
Pharmacokinetic Studies Confirm No Interaction
Multiple pharmacokinetic studies demonstrate that rosuvastatin and ezetimibe can be safely administered together:
A crossover study in healthy volunteers showed no clinically significant pharmacokinetic interactions when rosuvastatin and ezetimibe were coadministered. The 90% confidence intervals for both drugs' exposure parameters fell within bioequivalence ranges 3.
Another study specifically evaluated whether timing of administration (morning vs. evening) affected efficacy and found that LDL-C reduction was similar regardless of when the combination was taken (morning: 62.50 mg/dL vs. evening: 59.70 mg/dL; p=0.259) 4.
Fixed-dose combination tablets containing both drugs have been developed and approved, which by definition require simultaneous administration 5.
Important Exception: Bile Acid Sequestrants
The only timing consideration for ezetimibe is when used with bile acid sequestrants (cholestyramine, colestipol, colesevelam). In this specific scenario, ezetimibe must be taken either ≥2 hours before or ≥4 hours after the bile acid sequestrant 1. This restriction does not apply to statins like rosuvastatin.
Clinical Efficacy of the Combination
The combination demonstrates superior lipid-lowering compared to either agent alone:
- Ezetimibe added to statin therapy provides an incremental LDL-C reduction of approximately 25% 2
- Recent studies show LDL-C reductions of 50% or greater can be achieved with rosuvastatin/ezetimibe combinations 6
- The combination is particularly effective in elderly patients, with lower rates of statin-associated muscle symptoms (0.7% vs. 5.7% with high-intensity statin alone) 7
Practical Administration Recommendations
- Take both medications once daily at the same time to maximize adherence
- Can be taken with or without food
- Choose a consistent time (morning or evening) based on patient preference—efficacy is equivalent 4
- No need for dose separation or timing adjustments between the two drugs
The only drug-drug interaction concern mentioned in guidelines relates to cyclosporine, fibrates, and bile acid sequestrants—not to the timing of rosuvastatin and ezetimibe administration together 8, 1.